Clinical Trial Supply & Logistics Market - By Service Type (Logistics & Distribution), Phase (Phase I, Phase II), Therapeutic Area (Oncology, Ophthalmology), End-use, Global Forecast, 2023 – 2032

Clinical Trial Supply & Logistics Market - By Service Type (Logistics & Distribution), Phase (Phase I, Phase II), Therapeutic Area (Oncology, Ophthalmology), End-use, Global Forecast, 2023 – 2032

Clinical Trial Supply & Logistics Market Size

Clinical Trial Supply & Logistics Market size was valued at USD 3.7 billion in 2022 and is anticipated to grow with a CAGR of 7.9% by 2032, to reach an estimated value of USD 7.7 billion by 2032. The increasing prevalence of chronic diseases and the growing demand for novel therapies has spurred the number of clinical trials globally. This heightened research activity necessitates a well-organized supply chain to ensure timely and efficient delivery of investigational drugs and medical supplies.

Moreover, the globalization of clinical trials, with a growing number of studies conducted in emerging markets, has led to greater demand for specialized logistics services that can navigate complex regulatory environments.

Clinical trial supply and logistics refers to the management and distribution of investigational drugs, medical devices, or other materials required for conducting clinical trials, which are research studies involving human participants to evaluate the safety and effectiveness of new medical treatments or interventions. Effective supply and logistics management are critical to ensuring the smooth and ethical conduct of clinical trials.

COVID-19 Impact

The COVID-19 pandemic had a slight negative impact on the clinical trial supply and logistics market. The disruptions caused by the pandemic, including lockdowns, travel restrictions, and supply chain interruptions, created significant challenges for pharmaceutical companies conducting clinical trials. Many trials had to be delayed or suspended altogether, leading to increased costs and prolonged development timelines. Additionally, the heightened demand for healthcare resources strained the availability of skilled personnel and resources needed to manage clinical trial logistics effectively.

Clinical Trial Supply & Logistics Market Trends

The increasing number of clinical trials has emerged as a pivotal driver propelling the development of the clinical trial supply and logistics market. As the pharmaceutical and biotechnology industries continue to expand their research and development efforts, there has been a surge in the demand for efficient and reliable supply chain solutions to support these trials. This trend is fuelled by several factors, including the rising prevalence of complex and specialized therapies, globalization of clinical trials, and the imperative to expedite drug development processes. Consequently, pharmaceutical companies, contract research organizations (CROs), and other stakeholders are increasingly relying on specialized logistics providers to ensure the timely and seamless delivery of investigational drugs, medical devices, and other critical supplies to clinical trial sites worldwide.

Clinical Trial Supply & Logistics Restraint

Stringent regulatory requirements and varying regulations pose significant challenges and restraints for the clinical trial supply & logistics market. The pharmaceutical and biotechnology industries are subject to a complex web of rules and regulations imposed by different regulatory bodies in their respective countries. Meeting these stringent requirements demands meticulous planning and execution, which often leads to delays and increased costs in the supply chain. Furthermore, regulations can change rapidly, causing confusion and necessitating constant adaptation to remain compliant. This dynamic regulatory landscape adds a layer of complexity to the already intricate process of clinical trial logistics, making it crucial for companies to invest in expertise and technology that can navigate these challenges effectively while ensuring the timely and safe delivery of investigational drugs to clinical trial sites.

Clinical Trial Supply & Logistics Market  Analysis

By service type, the clinical trial supply & logistics market is segmented into logistics & distribution, storage & retention, packaging, labelling & blinding, drug manufacturing, comparator sourcing, and other services. Logistics & distribution segment is expected to grow at 7.7% CAGR over the coming years to reach USD 2.6 billion by end of 2032. As pharmaceutical companies race to develop and test new drugs and therapies, the need for efficient and reliable logistics and distribution services has become paramount. With clinical trials becoming increasingly global in scope, the need for efficient and secure transportation of sensitive materials such as investigational drugs, patient samples, and medical equipment has never been more critical. Moreover, the advent of precision medicine has created a demand for specialized logistics solutions that cater to the unique requirements of each trial.

By phase, the clinical trial supply & logistics market is segmented into Phase I, Phase II, Phase III, and Phase IV. Phase III segment accounted for USD 1.8 million in 2022. Phase III trials, often the final and pivotal stage in drug development, require large-scale testing on diverse patient populations, necessitating a robust supply chain and logistics infrastructure to ensure the seamless distribution of investigational drugs, medical supplies, and trial materials. As the pharmaceutical and biotechnology industries continue to expand their pipelines with promising drug candidates, the demand for phase III clinical trials has risen significantly.

Based on therapeutic area, the clinical trial supply & logistics market is segmented into oncology, infectious diseases, cardiovascular diseases, ophthalmology, dermatology, autoimmune disease, and other therapeutic areas. The oncology segment dominated the industry, with a market share of 39.8% in 2022. This surge can be attributed to several factors, including the increasing prevalence of cancer worldwide and the continuous development of innovative therapies and treatment modalities. As companies and research institutions strive to bring novel oncology drugs to market, the demand for efficient and reliable clinical trial supply and logistics services has soared. The complexity of oncology trials, with their diverse patient populations and stringent regulatory requirements, has also driven the need for specialized expertise in managing the supply chain.

Based on end-use, the clinical trial supply & logistics market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CROs), medical device companies, and other end-users. Pharmaceutical and biopharmaceutical companies segment is expected to reach USD 4.1 billion by 2032 owing to increasing investment of pharma and biotech companies in development of novel therapies and drugs. These companies have become pivotal players in clinical trials as they drive advancements in drug development and medical research. Their high progression can be attributed to their relentless pursuit of cutting-edge therapies, which necessitates extensive and efficient supply chain and logistics solutions. In an era of precision medicine, pharmaceutical and biotechnology firms are investing heavily in clinical trials.
 

North America dominated the clinical trial supply & logistics market with 55.4% market share in 2022. This region has consistently demonstrated its commitment to advancing healthcare and pharmaceutical research, resulting in a thriving clinical trials ecosystem. Factors contributing to this high expansion include a well-developed infrastructure, a skilled workforce, and a supportive regulatory environment.
 

Moreover, the North American pharmaceutical and biotechnology industries continue to drive innovation, necessitating a parallel growth in clinical trials to test and bring new therapies to market. With its dynamic and competitive landscape, North America remains a pivotal hub for clinical trials, attracting both domestic and international stakeholders seeking to capitalize on the burgeoning opportunities within this critical sector.
 

Clinical Trial Supply & Logistics Market Share

Market players operating in the clinical trial supply & logistics market is as mentioned below

• Thermo Fisher Scientific Inc. (Patheon)
• Catalent, Inc.
• Parexel
• Almac Group
• Marken
• Piramal Pharma Solutions
• UDG Healthcare
• DHL
• Movianto
• Packaging Coordinators Inc.

Within the clinical trial supply & logistics market, major industry players along with small and mid-size companies compete to offer advanced services in this space. Thermo Fisher Scientific, Piramal Pharm and Packaging Coordinators Inc accounts for largest market share in the overall industry. By meticulously assessing the market share of each company, considering factors such as the breadth of service offerings and customer satisfaction, one can unveil valuable insights into the competitive landscape of this market and strategically position themselves for success in this sector.
 

Clinical Trial Supply & Logistics Industry News

• In June 2022, Catalent expanded its primary packaging abilities by installing an elevated blister packaging line to enhance its already automated bottling line at its clinical supply facility in Shiga, Japan.
   
• In April 2021, Parexel and Veeva Systems entered a strategic collaboration to accelerate clinical trials through technology and process innovation. The unique collaboration combined the best of each company’s experience across thousands of studies worldwide to improve study efficiency and get new therapies to patients faster.
   

The clinical trial supply & logistics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments

Click here to Buy Section of this Report

By Service Type

• Logistics & distribution
• Storage & retention
• Packaging, labeling & blinding
• Drug manufacturing
• Comparator sourcing
• Other services

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By Therapeutic Area

• Oncology
• Infectious diseases
• Cardiovascular diseases
• Ophthalmology
• Dermatology
• Autoimmune disease
• Other therapeutic areas

By End-use

• Pharmaceutical & biotechnology companies
• Contract Research Organizations (CROs)
• Medical device companies
• Other end-users

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA